The H20 Summit on “The Future of Global Health Diplomacy in a Changing World” is set to take place from 19th to 20th June, 2024 at the World Health Organization (WHO) headquarters in Geneva, Switzerland. The event will feature over 150 distinguished guests and seven panels that will focus on the evolving role of global health diplomacy within the G20 and G7.
Key topics will include sustainable financing for global health, bridging the gap between investment and health communities, and introducing new global health initiatives. Additionally, the summit will launch the Global Legislators’ report on Antimicrobial Resistance (AMR), authored by prominent parliamentarians and experts. This report calls for a more systematic and common approach to tackling AMR at both global and national levels, emphasizing the critical role of parliamentarians in ensuring that health remains a political priority.
The H20 Summit is an independent annual platform launched in Geneva in 2018 by The G20 Health and Development Partnership’s Global Ambassadors and Member Organisations. Its goal is to support the agendas of G20 and G7 Presidencies by providing an inclusive and collaborative space for discussions. By bringing together traditional global health community members with sectors such as politics and finance, the H20 summits help create interdependencies and elevate global health challenges onto the political agendas of G20 policymakers and International Organizations. The event programme can be found on the H20 website.
In conclusion, The H20 Summit is an important platform for discussing global health issues with key stakeholders from various sectors, including politics, finance, healthcare providers, NGOs, academia, media among others. With its focus on sustainable financing for global health initiatives, bridging gaps between investment communities and other sectors that impact our lives positively or negatively is crucial to building resilient societies that prioritize public health wellbeing globally.
